• News and Press

The Latest News and Stories Related to the IMS Institute

Reuters: Global cancer drug spending to exceed $150 billion by 2020: IMS report

2016-6-2

Worldwide spending on cancer medicines will exceed $150 billion by 2020, driven by the emergence of expensive new therapies that help the immune system to attack tumors, according to a global oncology report released by IMS Health Holdings on Thursday.

CNBC: The world spent this much on cancer drugs last year

2016-6-2

Spending on cancer medicines totaled $107 billion worldwide in 2015 and is projected to exceed $150 billion by 2020, reflecting adoption of newer, pricier therapies, according to a report from the IMS Institute for Healthcare Informatics.

Washington Post: We’re spending $107 billion on cancer drugs, but is it worth it?

2016-6-2

A flood of innovative cancer treatments helped fuel an 11.5 percent surge in spending on oncology drugs over the past year -- to $107 billion globally, according to a new report. But there's a crucial question the study can't quite answer: How much are patients benefiting from this expanding arsenal of high-priced drugs?

CBS MoneyWatch: The ever-escalating cost of cancer drugs

2016-6-2

The total cost of oncology drugs and supportive care medications surged 11.5 percent in 2015 to reach $107 billion globally, according to a new study from IMS Institute for Healthcare Informatics. The spending is based on invoice prices, the amount hospitals or pharmacies paid to distributors.

Business Insider: We're in the middle of a gold rush in the cancer-drug industry

2016-6-2

In the past five years, 70 new cancer treatments have been approved for more than 20 types of tumors.

Reuters: U.S. prescription drug spending to hit $400 billion a year by 2020: IMS

2016-4-14

U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

Bloomberg: Prescription Drug Spending Hits Record $425 Billion in U.S.

2016-4-14

Spending on prescription drugs in the U.S. rose 12 percent to a record $425 billion before discounts last year, boosted in part by the introduction of breakthrough medicines for cancer and the growing number of patients seeking treatment for hepatitis C.

IMS Health Study: U.S. Drug Spending Growth Reaches 8.5 Percent in 2015

2016-4-14

Specialty Medicine innovation continued to drive growth last year, partially offset by price concessions from pharma manufacturers.

See More

To learn more about ways that the IMS Institute can support your initiatives, please reach out to our team:

 

*Required